Boron Neutron Capture Therapy (BNCT) is based on the ability of the stable isotope 10B to capture neutrons, which leads to a nuclear
reaction producing an alpha- and a 7Li-particle, both having a high biological effectiveness and a very short range in tissue, being limited to
approximately one cell diameter. This opens the possibility for a highly selective cancer therapy. BNCT strongly depends on the selective
uptake of 10B in tumor cells and on its distribution inside the cells. The chemical properties of boron and the need to discriminate different
isotopes make the investigation of the concentration and distribution of 10B a challenging task. The most advanced techniques to measure and image boron are described, both invasive and non-invasive. The most promising approach for further investigation will be the complementary use of the different techniques to obtain the information that is mandatory for the future of this innovative treatment modality.
WITTIG Andrea;
MICHEL Jean;
MOSS Raymond;
STECHER-RASMUSSEN Finn;
ARLINGHAUS Heinrich;
BENDEL Peter;
MAURI Pierluigi;
ALTIERI Saverio;
HILGER Ralf;
SALVADORI Piero;
MENICHETTI Luca;
ZAMENHOF Robert;
SAUERWEIN Wolfgang;
2009-12-10
ELSEVIER SCIENCE INC
JRC48341
1040-8428,
http://www.croh-online.com/issues/contents?issue_key=S1040-8428X0009-5,
https://publications.jrc.ec.europa.eu/repository/handle/JRC48341,
10.1016/j.critrevonc.2008.03.004,
| Name | Country | City | Type |
|---|
This document is only visible at the Commission level.
You are not authorized to publish or distribute it outside the European Commission.
This is a public document. You can share this publication.
Datasets
| ID | Title | Public URL |
|---|
Dataset collections
| ID | Acronym | Title | Public URL |
|---|
Scripts / source codes
| Description | Public URL |
|---|
Additional supporting files
| File name | Description | File type |
|---|